drugset / Trial / NCT03758014
Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients
Phase 2/3
Unknown
200 enrolled
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of phase II/III study: Determining the Overall Survival（OS）of Chlorogenic acid for injection comparing to in the advanced Glioblastoma Patients through study completion（an average of 18 months）after the first dose of chlorogenic acid for injection and Lomustine.
Timeline
- Start
- 2018-11-27
- Primary completion
- 2020-10-30
- Completion
- 2021-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chlorogenic acid | Small molecule | 3 mg/kg | Other |
| Comparator | Lomustine | Small molecule | 110 mg/m2 | Oral |